液体活检在肾细胞癌中的应用。
Liquid biopsy in renal cell carcinoma.
机构信息
Dana-Farber Cancer Institute, Boston, MA, United States.
Harvard Medical School, Boston, MA, United States.
出版信息
Oncologist. 2024 Oct 3;29(10):821-823. doi: 10.1093/oncolo/oyae230.
Abstract
This commentary focuses on the article by Correa et al on the association of circulating tumor DNA with patient prognosis in renal cell carcinoma.
摘要
这篇评论聚焦于 Correa 等人关于循环肿瘤 DNA 与肾细胞癌患者预后相关性的文章。
相似文献
1
Liquid biopsy in renal cell carcinoma.液体活检在肾细胞癌中的应用。
Oncologist. 2024 Oct 3;29(10):821-823. doi: 10.1093/oncolo/oyae230.
2
Incidental discovery of a renal cell carcinoma on native kidney biopsy.在对天然肾活检时偶然发现肾细胞癌。
Am J Kidney Dis. 2010 Jul;56(1):175-80. doi: 10.1053/j.ajkd.2009.08.018. Epub 2009 Oct 31.
3
Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application.液体活检在肾细胞癌前沿的应用：技术分析与临床应用的最新进展。
Mol Cancer. 2023 Feb 21;22(1):37. doi: 10.1186/s12943-023-01745-7.
4
Percutaneous renal biopsy may aid management of small renal masses on active surveillance.经皮肾活检可能有助于对主动监测的小肾肿块进行管理。
Can J Urol. 2013 Apr;20(2):6742.
5
Spontaneous Regression of a Low-Grade Renal Cell Carcinoma With Oncocytic Features After Renal Mass Biopsy.肾肿块活检后具有嗜酸性细胞特征的低级别肾细胞癌自发消退
Clin Genitourin Cancer. 2018 Dec;16(6):e1083-e1085. doi: 10.1016/j.clgc.2018.07.012. Epub 2018 Jul 21.
6
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art.肾细胞癌复发的生物标志物：现状。
Curr Urol Rep. 2021 Apr 22;22(6):31. doi: 10.1007/s11934-021-01050-0.
7
Renal cell carcinoma needle biopsy: sowing the seed for later complications?肾细胞癌针吸活检：为日后并发症埋下隐患？
BMJ Case Rep. 2014 Apr 30;2014:bcr2014203691. doi: 10.1136/bcr-2014-203691.
8
Kidney cancer: Undertreatment of small renal masses by overuse of biopsy.
Nat Rev Urol. 2016 Dec;13(12):701-703. doi: 10.1038/nrurol.2016.213. Epub 2016 Nov 2.
9
[Pathology of benign and malignant renal cell tumors].[良性与恶性肾细胞肿瘤的病理学]
Urologe A. 1991 Nov;30(6):W41-50.
10
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.液体活检的蛋白质组学：通过尿液和血浆的 MS 分析描绘 RCC 浸润至肾静脉。
J Proteomics. 2019 Jan 16;191:29-37. doi: 10.1016/j.jprot.2018.04.029. Epub 2018 Apr 22.
引用本文的文献
1
Tumor-Educated Platelets in Urological Tumors: A Novel Biosource in Liquid Biopsy.泌尿系统肿瘤中的肿瘤衍生血小板：液体活检中的新型生物来源
Int J Mol Sci. 2025 Apr 11;26(8):3595. doi: 10.3390/ijms26083595.
本文引用的文献
1
Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma.循环肿瘤 DNA 与手术切除肾细胞癌患者预后的相关性。
Oncologist. 2024 Oct 3;29(10):887-893. doi: 10.1093/oncolo/oyae180.
2
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma.肉瘤样分化的表观基因组特征指导肾细胞癌的治疗。
Cell Rep. 2024 Jun 25;43(6):114350. doi: 10.1016/j.celrep.2024.114350. Epub 2024 Jun 12.
3
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.帕博利珠单抗辅助治疗用于肾细胞癌的总生存期。
N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695.
4
Liquid biopsy epigenomic profiling for cancer subtyping.液体活检的表观基因组特征分析用于癌症分型。
Nat Med. 2023 Nov;29(11):2737-2741. doi: 10.1038/s41591-023-02605-z. Epub 2023 Oct 21.
5
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies.对晚期泌尿生殖系统恶性肿瘤患者进行循环肿瘤 DNA 的纵向监测，以评估免疫检查点抑制剂的疗效。
JCO Precis Oncol. 2023 Jul;7:e2300131. doi: 10.1200/PO.23.00131.
6
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma.超敏循环肿瘤 DNA 初步研究区分转移性肾细胞癌患者免疫治疗完全缓解与部分缓解。
JCO Precis Oncol. 2023 Apr;7:e2200543. doi: 10.1200/PO.22.00543.
7
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer.结直肠癌患者的分子残留疾病与辅助化疗疗效。
Nat Med. 2023 Jan;29(1):127-134. doi: 10.1038/s41591-022-02115-4. Epub 2023 Jan 16.
8
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.ctDNA 指导尿路上皮癌的辅助免疫治疗。
Nature. 2021 Jul;595(7867):432-437. doi: 10.1038/s41586-021-03642-9. Epub 2021 Jun 16.
9
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma.循环肿瘤 DNA 评估与组织基因组分析在转移性肾细胞癌中的互补作用。
Clin Cancer Res. 2021 Sep 1;27(17):4807-4813. doi: 10.1158/1078-0432.CCR-21-0572. Epub 2021 Jun 15.
10
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.循环肿瘤细胞在转移性肾细胞癌中的预后作用：一项大型、多中心、前瞻性试验
Oncologist. 2021 Sep;26(9):740-750. doi: 10.1002/onco.13842. Epub 2021 Jun 17.
Zotero 插件